Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Targeting clonal mutations with synthetic microbes
Michael Renteln
Read the full article
See related articles
Discuss this preprint
Start a discussion
What are Sciety discussions?
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1016/j.critrevonc.2024.104572
Feb 1, 2025
Version published to 10.20944/preprints202308.1536.v11
Sep 11, 2024
Version published to 10.20944/preprints202308.1536.v10
Aug 23, 2024
Version published to 10.20944/preprints202308.1536.v9
Aug 7, 2024
Version published to 10.20944/preprints202308.1536.v8
Jul 1, 2024
Version published to 10.20944/preprints202308.1536.v7
Jun 7, 2024
Version published to 10.20944/preprints202308.1536.v6
May 9, 2024
Version published to 10.20944/preprints202308.1536.v5
Mar 22, 2024
Version published to 10.20944/preprints202308.1536.v4
Feb 5, 2024
Version published to 10.20944/preprints202308.1536.v3
Jan 2, 2024
Version published to 10.20944/preprints202308.1536.v2
Sep 7, 2023
Version published to 10.20944/preprints202308.1536.v1
Aug 22, 2023
Related articles
Targeting Clonal Mutations in Solid Tumors with Personalized Oncolytic Microbes
This article has 1 author:
Michael Renteln
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients
This article has 12 authors:
Patricia Garcia Pastor
Nadia Saoudi González
Francesc Salva
Javier Ros
Iosune Baraibar
Marta Rodríguez Castells
Clara Salva de Torres
Ariadna García
Adriana Alcaraz
Caterina Vaghi
Josep Tabernero
Elena Elez
Targeted Cancer Therapy Has Been Defined at a Narrow Biological Level—A Hierarchical and Semi-Quantitative Reassessment of Genomic, Redox, and Metabolic Targeting
This article has 1 author:
Richard Cheng
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up